No abstract available
MeSH terms
-
Adenocarcinoma / blood*
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / immunology
-
Adenocarcinoma / radiotherapy
-
Adenocarcinoma / surgery
-
Androgen Antagonists / therapeutic use
-
Antibodies, Heterophile / immunology*
-
Antigen-Antibody Reactions
-
Antigens, Neoplasm / immunology
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Biomarkers, Tumor / blood*
-
Biomarkers, Tumor / immunology
-
Case Management*
-
Cross Reactions
-
False Positive Reactions
-
Follow-Up Studies
-
Humans
-
Immunoenzyme Techniques*
-
Immunoradiometric Assay*
-
Luminescent Measurements
-
Male
-
Microspheres
-
Middle Aged
-
Neoplasm Proteins / blood*
-
Neoplasm Proteins / immunology
-
Neoplasm Recurrence, Local / diagnosis*
-
Prostate-Specific Antigen / blood*
-
Prostate-Specific Antigen / immunology
-
Prostatectomy
-
Prostatic Neoplasms / blood*
-
Prostatic Neoplasms / drug therapy
-
Prostatic Neoplasms / immunology
-
Prostatic Neoplasms / radiotherapy
-
Prostatic Neoplasms / surgery
-
Radiotherapy, Adjuvant
-
Unnecessary Procedures
Substances
-
Androgen Antagonists
-
Antibodies, Heterophile
-
Antigens, Neoplasm
-
Antineoplastic Agents, Hormonal
-
Biomarkers, Tumor
-
Neoplasm Proteins
-
Prostate-Specific Antigen